Relationships between blood glucose level, cardiac autonomic function and occurrence of arrhythmia in using oral hypoglycemic or antiarrhythmic drugs.
Not Applicable
Recruiting
- Conditions
- Type1 and type2 diabetes mellitus, tachyarrhythmia
- Registration Number
- JPRN-UMIN000007777
- Lead Sponsor
- Chiba University Graduate School of Medicine, Department of Cardiovascular Medicine and Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who meet any criterias shown below sholud be excluded. 1)Those who can not write consent. 2)Patients who are considered inappropriate to mount continuous monitoring device. 3)Anyone whom our person in charge regaerd unsuitable for the present study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link blood glucose levels to cardiac autonomic dysfunction in diabetic patients?
How do oral hypoglycemic agents affect arrhythmia risk in type 1 and type 2 diabetes mellitus populations?
Which biomarkers correlate with cardiac autonomic function and arrhythmia occurrence in diabetic patients receiving antiarrhythmic drugs?
What are the potential adverse events associated with combined oral hypoglycemic and antiarrhythmic drug therapy in diabetes patients?
How does the GLAFITE study compare to other observational trials on diabetes-cardiac autonomic function interactions and arrhythmia management?